Internet addiction disorder and problematic use of Google Glass™ in patient treated at a residential substance abuse treatment program

K Yung, E Eickhoff, DL Davis, WP Klam, AP Doan - Addictive behaviors, 2015 - Elsevier
Introduction Internet addiction disorder (IAD) is characterized by the problematic use of online
video games, computer use, and mobile handheld devices. While not officially a clinical …

Methicillin-resistant Staphylococcus aureus fomite survival

C Williams, DL Davis - American Society for Clinical Laboratory …, 2009 - clsjournal.ascls.org
OBJECTIVE: To assess survival of methicillin-resistant Staphylococcus aureus (MRSA) on
fomites encountered by health students. DESIGN: Three suspensions of MRSA were made to …

Excessive video game use, sleep deprivation, and poor work performance among US Marines treated in a military mental health clinic: a case series

E Eickhoff, K Yung, DL Davis, F Bishop… - Military …, 2015 - academic.oup.com
Excessive use of video games may be associated with sleep deprivation, resulting in poor
job performance and atypical mood disorders. Three active duty service members in the US …

Tacrolimus metabolite cross-reactivity in different tacrolimus assays

JN Murthy, DL Davis, RW Yatscoff, SJ Soldin - Clinical biochemistry, 1998 - Elsevier
Objectives: Tacrolimus (FK506) is an immunosuppressive drug with great clinical promise.
There is a controversy regarding the role of tacrolimus metabolites in immunosuppression …

Identification of ubiquitin as an immunophilin

DL Davis, SJ Soldin - Biochemical and biophysical research …, 2000 - Elsevier
We have identified an 8.4 kDa minor immunophilin from calf thymus and Jurkat T cells as
ubiquitin. It binds tacrolimus and sirolimus with K d 's of 0.8 and 0.08 nM, respectively. The …

Protein ubiquitin is an immunophilin

DL Davis, SJ Soldin - Therapeutic drug monitoring, 2002 - journals.lww.com
The intracellular class of proteins that bind the interleukin-2 suppressing drugs (cyclosporin,
tacrolimus, and sirolimus) are called immunophilins. It is believed that the drugs do not act …

An immunophilin-binding assay for sirolimus

DL Davis, SJ Soldin - Clinical therapeutics, 2000 - Elsevier
OBJECTIVE: This review examines the performance of 4 assays for sirolimus in terms of
their ability to meet 6 guidelines determined by a panel of experts. BACKGROUND: Four …

Comparison of steady-state trough sirolimus samples by HPLC and a radioreceptor assay

DL Davis, JN Murthy, KL Napoli, BD Kahan… - Clinical …, 2000 - Elsevier
Objectives: We have previously identified a minor immunophilin of 52 kDa molecular weight
capable of binding tacrolimus and sirolimus. Because immunophilins are capable of binding …

Minor immunophilin binding of tacrolimus and sirolimus metabolites

DL Davis, JN Murthy, H Gallant-Haidner, RW Yatscoff… - Clinical …, 2000 - Elsevier
Objectives: We have previously identified three minor immunophilins of molecular weights
37 kDa, 14 kDa, and 5–8 kDa capable of binding tacrolimus and sirolimus. Design and …

Biochemical characterization of the minor immunophilins

DL Davis, JN Murthy, SJ Soldin - Clinical biochemistry, 2000 - Elsevier
Objective: We present biochemical characterization of the previously described 14 kDa, 37
kDa, and 52 kDa immunophilins and a newly identified 5–8 kDa immunophilin. Design and …